Results from a clinical trial suggest that semaglutide, the substance in Ozempic and Wegovy, can halt and even reverse a ...

That BJP has gradually replaced the Congress as the dominant party in Indian politics is an obvious trend. But the big picture shows another interesting trend -- regional parties can’t be ...

More than 1,800 students have lost their F-1 or J-1 student status as part of the Trump administration’s crackdown on immigration and alleged antisemitism, according to news reports and college ...

While there is not currently a shortage of Ozempic, previous difficulties in supplying this medication have led to some pharmacies offering compounded semaglutide. The Food and Drug Administration ...

New Delhi: In line with the proposal for approval of Semaglutide tablets 1.5 mg, 4 mg, 9 mg of new formulation based on the bioequivalence (BE) studies conducted in USA and Canada, the Subject Expert ...

Conversely, Lilly's stock price jumped about 14.5% to $840. “While Novo had the headstart with approval of semaglutide, we believe that this first mover advantage has waned, with Lilly's ...

Although different active ingredients - Mounjaro is tirzepatide and Ozempic and Wegovy is semaglutide - they all work by mimicking hormones that tell the brain the stomach is full, releasing ...

If approved, orforglipron would offer an alternative to another GLP-1 pill, Rybelsus (semaglutide). That medication has been available by prescription since 2019 for the treatment of Type 2 ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. The phase 3 study linked the oral GLP-1 drug orforglipron to similar reductions in blood glucose and body ...

This infographic presents key findings from a comprehensive new report on how well physicians are paid in this country. To learn more, check out the Medscape Physician Compensation Report 2025.

Infographics: Dynamic digital data analysis Special reports Infographics: Dynamic digital data analysis Trump administration impacts Biopharma M&A scorecard BioWorld 2024 review BioWorld MedTech 2024 ...